Andrew I. Koven is President at Aralez Pharmaceuticals Inc. (ARLZ). They have made 5 open-market trades across 2 companies since 2014, most recently 2026-06-08.
CIK 0001258673
Unrated. We grade insiders only on stock they chose to buy on the open market. Grants, option exercises and vesting say nothing about timing, so they don't count — which is why someone can file often and still have no grade. It isn't a bad sign: unrated buys beat every graded tier below A.
2 open-market purchases totalling $550K since 2016, against 3 sales. Too few scored purchases to measure a record yet.
| Ticker | Type | Traded | Filed | Price | Value | 7d Stock | 30d Stock | 90d Stock |
|---|---|---|---|---|---|---|---|---|
| ARLZ | SELL | 2018-06-04 | 2018-06-06 | $0.37 | $116K | +14.3% | -14.0% | N/A |
| ARLZ | SELL · 10b5-1 | 2018-05-14 | 2018-05-16 | $0.52 | $7K | -18.5% | -8.3% | -86.8% |
| ARLZ | SELL · 10b5-1 | 2018-03-19 | 2018-03-21 | $1.70 | $17K | -12.5% | -17.3% | -75.8% |
| ARLZ | SELL | 2017-06-05 | 2017-06-06 | $1.28 | $414K | -9.7% | +3.0% | -11.2% |
| ARLZ | SELL · 10b5-1 | 2017-03-20 | 2017-03-22 | $2.41 | $19K | -8.7% | -31.4% | -49.8% |
| ARLZ | BUY | 2017-03-15 | 2017-03-17 | $2.55 | $51K | -11.8% | -36.5% | -54.9% |
| ARLZ | BUY | 2016-05-12 | 2016-05-13 | $3.49 | $499K | +15.7% | -1.1% | +25.1% |
| AUXL | SELL | 2014-11-21 | 2014-11-24 | $33.43 | $4.7M | N/A | N/A | N/A |
Grouped by shared companies and similar filing behaviour. This is a similarity measure, not a ranking or a performance signal.
| — |
| Total | $113K |